These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12639562)

  • 21. Design, synthesis and preliminary screening of novel 3-(2-N,N-dimethylaminoethylthio) indole derivatives as potential 5-HT(6) receptor ligands.
    Kambhampati R; Konda J; Reballi V; Shinde AK; Dubey PK; Nirogi RV
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):302-12. PubMed ID: 18569332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.
    Sanner MA; Chappie TA; Dunaiskis AR; Fliri AF; Desai KA; Zorn SH; Jackson ER; Johnson CG; Morrone JM; Seymour PA; Majchrzak MJ; Faraci WS; Collins JL; Duignan DB; Prete Di CC; Lee JS; Trozzi A
    Bioorg Med Chem Lett; 1998 Apr; 8(7):725-30. PubMed ID: 9871530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles.
    Perregaard J; Arnt J; Bøgesø KP; Hyttel J; Sánchez C
    J Med Chem; 1992 Mar; 35(6):1092-101. PubMed ID: 1348090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands.
    Curtis NR; Kulagowski JJ; Leeson PD; Ridgill MP; Emms F; Freedman SB; Patel S; Patel S
    Bioorg Med Chem Lett; 1999 Feb; 9(4):585-8. PubMed ID: 10098669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenylpiperazinylmethylindolecarboxylates and derivatives as selective D(4)-ligands.
    Moll A; Hübner H; Gmeiner P; Troschütz R
    Bioorg Med Chem; 2002 Jun; 10(6):1671-9. PubMed ID: 11937325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.
    Cummings DF; Ericksen SS; Goetz A; Schetz JA
    J Pharmacol Exp Ther; 2010 Jun; 333(3):682-95. PubMed ID: 20215412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.
    Lee T; Robichaud AJ; Boyle KE; Lu Y; Robertson DW; Miller KJ; Fitzgerald LW; McElroy JF; Largent BL
    Bioorg Med Chem Lett; 2003 Feb; 13(4):767-70. PubMed ID: 12639577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New generation dopaminergic agents. 6. Structure-activity relationship studies of a series of 4-(aminoethoxy)indole and 4-(aminoethoxy)indolone derivatives based on the newly discovered 3-hydroxyphenoxyethylamine D2 template.
    Mewshaw RE; Webb MB; Marquis KL; McGaughey GB; Shi X; Wasik T; Scerni R; Brennan JA; Andree TH
    J Med Chem; 1999 Jun; 42(11):2007-20. PubMed ID: 10354409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
    Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
    J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively.
    Pillai G; Brown NA; McAllister G; Milligan G; Seabrook GR
    Neuropharmacology; 1998 Aug; 37(8):983-7. PubMed ID: 9833627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
    Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-Aminoindoles as 1,4-bisnucleophiles for diversity-oriented synthesis of tricyclic indoles bearing 3,4-fused seven-membered rings.
    Chen S; Ravichandiran P; El-Harairy A; Queneau Y; Li M; Gu Y
    Org Biomol Chem; 2019 Jun; 17(24):5982-5989. PubMed ID: 31166351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles.
    Buemi MR; De Luca L; Ferro S; Gitto R
    Arch Pharm (Weinheim); 2014 Aug; 347(8):533-9. PubMed ID: 24862313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists.
    Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD
    J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina.
    Patel S; Chapman KL; Marston D; Hutson PH; Ragan CI
    Neuropharmacology; 2003 Jun; 44(8):1038-46. PubMed ID: 12763097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.